MIT Holding, Inc.’s (MITD) Home Health Services
Post# of 36
Nearly 14% of Medicare patients discharged to a skilled nursing facility (SNF) after a hospital stay are readmitted to the hospital for conditions that could have been avoided with better care, according to MedPAC analysis. A collaborative effort between the Partnership for Patients and the Center for Medicare and Medicaid Services (CMS) aims to reduce hospital readmissions by 20% and save the healthcare system tens of billions of dollars in upcoming years. MIT Holding has a complementary approach: a single source of high-quality, low cost need-fulfillment for patients provided during their at-home recovery.
Research shows that sufficient homecare recovery after a hospital stay can drastically reduce mental and physical stresses on the patient, minimize the length of recovery and associated costs, and reduce the risk of hospital re-admission and hospital acquired conditions.
MIT Holding has built its business model around this concept, and works through its growing network of accredited agents, facilitators and contractual obligations to operate as a single-source provider of professional outpatient medical care including pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies, in addition to home medical equipment for sale or for rent.
The company also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.
Furthermore, as an accredited healthcare provider, MIT is in full compliance with major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators.
In June, 2014, MIT achieved its first profitable quarter in six years, and each company subsidiary is now operating with objectives of a 32% net profit. This profitability validates MIT’s approach to the evolving Affordable Health Care Act as well as the company’s impact on patient recovery and the broader healthcare industry.
MIT recently completed successful beta testing of its concept in Georgia and now plans to expand its first-of-its-kind approach nationwide via one acquisition per each quarter of 2015. The company’s broader business model is focused on building shareholder value, revenues and corporate expansion while providing viable solutions to the changing care sector.
For more information, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com